查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1559638

RSV 診斷的全球市場

RSV Diagnostics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 233 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球 RSV 診斷市場預計將達到 12 億美元

RSV 診斷的全球市場預計 2023 年為 7.684 億美元，預計到 2030 年將達到 12 億美元，在 2023-2030 年分析期間複合年成長率為 6.9%。 RSV 診斷試劑套件和檢測是本報告分析的細分市場之一，複合年成長率為 7.7%，預計到分析期結束時將達到 6.866 億美元。分析期間，RSV 診斷儀器領域的複合年成長率預計為 6.3%。

美國市場預估為2.035億美元，中國預期複合年成長率為11.6%

預計 2023 年美國RSV 診斷市場規模將達 2.035 億美元。中國作為全球第二大經濟體，預計2030年市場規模將達3.058億美元，2023-2030年分析期間複合年成長率為11.6%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 2.7% 和 7.0%。在歐洲，德國的複合年成長率預計為 3.7%。

全球 RSV 診斷市場 – 主要趨勢與促進因素總結

什麼是 RSV 診斷？ RSV 對嬰幼兒、幼兒、老年人和免疫力缺乏的人尤其危險，會導致嚴重的呼吸道疾病，如支氣管炎和肺炎。早期準確的診斷對於有效的管理和治療至關重要，因為它可以防止病毒傳播並及時介入。 RSV 診斷包括聚合酵素鏈鎖反應(PCR)、抗原檢測和血清學檢測等分子檢測，每種檢測的敏感度、特異性和周轉時間各不相同。隨著人們越來越認知到 RSV 對易感人群的影響，臨床和 POC 對高效、快速診斷解決方案的需求不斷增加。

技術進步如何形塑 RSV 診斷市場？
技術進步在提高 RSV 診斷的準確性、速度和可及性方面發揮著至關重要的作用。可在幾分鐘內提供結果的快速抗原測試的發展正在徹底改變照護現場診斷，並使 RSV 測試在門診和急診護理環境中更容易進行。分子診斷學的進步，特別是即時PCR和核酸增幅檢查(NAAT)，提供了更高的靈敏度和特異性，可以檢測檢體中的低病毒量。引入可同時檢測 RSV 和其他呼吸道病原體（例如流感和 COVID-19）的多重檢測組合，可提高診斷效率並實現全面的呼吸道疾病管理。此外，數位平台和遠端醫療的使用正在促進遠距離診斷和諮詢，增加患者獲得治療的機會。此類創新正在擴大 RSV 診斷的範圍和有效性，並促進已開發和發展中地區的採用。

RSV 診斷市場有哪些挑戰與機會？
RSV 診斷市場面臨多項挑戰，包括先進診斷測試的高成本、測試準確性的變化以及需要熟練人員操作複雜的診斷設備。 PCR 等分子診斷測試的高成本可能成為廣泛使用的障礙，特別是在資源匱乏的環境中。此外，不同測試的敏感性和特異性的差異可能導致假陽性和假陰性，進而影響臨床決策。然而，這些挑戰也帶來了巨大的成長和創新機會。人們對 RSV 及其對公共衛生影響的認知不斷提高，加上全球呼吸系統疾病的增加，正在推動對有效且負擔得起的診斷解決方案的需求。對早期檢測和預防性醫療保健的日益關注進一步增強了市場潛力。此外，遠端醫療和遠距離診斷的擴展為 RSV 診斷提供者提供創新且易於使用的解決方案創造了新的機會。

推動 RSV 診斷市場成長的因素有哪些？
RSV 診斷市場的成長受到多種因素的推動，包括 RSV 感染發病率的上升，特別是在嬰幼兒、老年人和免疫力缺乏人群中。快速抗原檢測、即時PCR、多重檢測和數位診斷的技術進步正在提高 RSV 診斷的準確性、速度和可及性，從而提高了 RSV 診斷的採用率。對早期診斷、預防性護理的日益關注以及將 RSV 與流感和 COVID-19 等其他呼吸道疾病區分開來的需求也有助於市場成長。此外，擴大醫療基礎設施（特別是在新興市場）以及在基層醫療機構中擴大採用就地檢驗也推動了對 RSV 診斷的需求。對改善患者治療結果、減少住院治療和盡量減少 RSV 傳播的關注進一步推動 RSV 診斷市場向前發展。

受訪企業範例（共166家）

  • Abbott Molecular
  • Apollo Diagnostics
  • Becton, Dickinson and Company
  • Biomeb
  • BIOMED Labordiagnostik GmbH
  • bioMerieux SA
  • Bioperfectus Technologies
  • BioReference Laboratories, Inc.
  • Cellgen Diagnostics
  • Cepheid

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP14514

Global RSV Diagnostics Market to Reach US$1.2 Billion by 2030

The global market for RSV Diagnostics estimated at US$768.4 Million in the year 2023, is expected to reach US$1.2 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2023-2030. RSV Diagnostics Kits & Assays, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$686.6 Million by the end of the analysis period. Growth in the RSV Diagnostics Instruments segment is estimated at 6.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$203.5 Million While China is Forecast to Grow at 11.6% CAGR

The RSV Diagnostics market in the U.S. is estimated at US$203.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$305.8 Million by the year 2030 trailing a CAGR of 11.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 7.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global RSV Diagnostics Market - Key Trends and Drivers Summarized

What Are RSV Diagnostics and Why Are They Critical for Public Health?
Respiratory Syncytial Virus (RSV) diagnostics involve a range of tests and procedures designed to detect the presence of RSV, a common respiratory virus that causes infections in the lungs and respiratory tract. RSV is particularly dangerous for infants, young children, the elderly, and immunocompromised individuals, leading to severe respiratory illnesses such as bronchiolitis and pneumonia. Early and accurate diagnosis is crucial for effective management and treatment, as it helps prevent the spread of the virus and enables timely intervention. RSV diagnostics include molecular tests like Polymerase Chain Reaction (PCR), antigen detection tests, and serological assays, each providing different levels of sensitivity, specificity, and turnaround times. As the awareness of RSV's impact on vulnerable populations grows, the demand for efficient and rapid diagnostic solutions is rising in both clinical and point-of-care settings.

How Are Technological Advancements Shaping the RSV Diagnostics Market?
Technological advancements are playing a pivotal role in enhancing the accuracy, speed, and accessibility of RSV diagnostics. The development of rapid antigen tests that provide results in minutes is revolutionizing point-of-care diagnostics, making RSV testing more accessible in outpatient and emergency care settings. Advances in molecular diagnostics, particularly in real-time PCR and nucleic acid amplification tests (NAATs), are offering higher sensitivity and specificity, allowing for the detection of even low viral loads in samples. The introduction of multiplex panels that can simultaneously test for RSV and other respiratory pathogens, such as influenza and COVID-19, is improving diagnostic efficiency and enabling comprehensive respiratory illness management. Additionally, the use of digital platforms and telemedicine is facilitating remote diagnosis and consultation, enhancing patient access to care. These technological innovations are expanding the scope and effectiveness of RSV diagnostics, driving their adoption in both developed and developing regions.

What Challenges and Opportunities Exist in the RSV Diagnostics Market?
The RSV diagnostics market faces several challenges, including high costs of advanced diagnostic tests, variability in test accuracy, and the need for skilled personnel to operate complex diagnostic equipment. The high cost of molecular diagnostic tests, such as PCR, can be a barrier to widespread adoption, particularly in low-resource settings. Additionally, variations in the sensitivity and specificity of different tests can lead to false positives or negatives, affecting clinical decision-making. However, these challenges present significant opportunities for growth and innovation. The increasing awareness of RSV and its impact on public health, coupled with the rise in global respiratory illnesses, is driving demand for effective and affordable diagnostic solutions. The growing focus on early detection and preventive healthcare is further boosting market potential. Moreover, the expansion of telehealth and remote diagnostics is creating new opportunities for RSV diagnostics providers to offer innovative and accessible solutions.

What Factors Are Driving the Growth of the RSV Diagnostics Market?
The growth in the RSV Diagnostics market is driven by several factors, including the rising incidence of RSV infections, particularly among infants, the elderly, and immunocompromised populations. Technological advancements in rapid antigen tests, real-time PCR, multiplex panels, and digital diagnostics are enhancing the accuracy, speed, and accessibility of RSV diagnostics, driving their adoption. The increasing focus on early diagnosis, preventive healthcare, and the need to differentiate RSV from other respiratory illnesses, such as influenza and COVID-19, is also contributing to market growth. Additionally, the expansion of healthcare infrastructure, particularly in emerging markets, and the growing adoption of point-of-care testing in primary care settings are boosting the demand for RSV diagnostics. The emphasis on improving patient outcomes, reducing hospitalizations, and minimizing the spread of RSV is further propelling the RSV diagnostics market forward.

Select Competitors (Total 166 Featured) -

  • Abbott Molecular
  • Apollo Diagnostics
  • Becton, Dickinson and Company
  • Biomeb
  • BIOMED Labordiagnostik GmbH
  • bioMerieux SA
  • Bioperfectus Technologies
  • BioReference Laboratories, Inc.
  • Cellgen Diagnostics
  • Cepheid

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • RSV Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Early Detection and Diagnosis of Respiratory Syncytial Virus (RSV) Propels Market Growth
    • Increasing Use in Pediatric and Elderly Populations Expands Addressable Market Opportunity
    • Technological Advancements in Molecular and Point-of-Care Diagnostics Strengthen Market Position
    • Growing Focus on Preventing RSV-Related Complications Drives Adoption of Advanced Diagnostics
    • Surge in Demand for Rapid and Accurate RSV Testing Generates New Opportunities
    • Expanding Applications in Outpatient Clinics and Home Testing Throws Spotlight on Market Potential
    • Growth in Awareness and Screening Programs for Respiratory Infections Spurs Demand for RSV Diagnostics
    • Surge in Demand for RSV Testing During Flu Season and Outbreaks Expands Market Horizons
    • Growing Awareness of the Benefits of Early RSV Diagnosis in Reducing Hospitalizations Drives Market Adoption
    • Innovations in Portable and Digital Diagnostic Devices Generate New Market Opportunities
    • Rising Demand for RSV Diagnostics in Hospital and Ambulatory Care Settings Throws Spotlight on Market Dynamics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for RSV Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for RSV Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for RSV Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Kits & Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Kits & Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Kits & Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Rapid Antigen Detection Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Rapid Antigen Detection Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Rapid Antigen Detection Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Other Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Other Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World RSV Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • JAPAN
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • CHINA
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • EUROPE
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for RSV Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for RSV Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for RSV Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • FRANCE
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • GERMANY
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for RSV Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for RSV Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for RSV Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • INDIA
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for RSV Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for RSV Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for RSV Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for RSV Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for RSV Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for RSV Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • AFRICA
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030

IV. COMPETITION